| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |